J&J’s Consumer Sales Buoyed By Listerine In Third Quarter
This article was originally published in The Tan Sheet
Johnson & Johnson's Listerine mouthwash brand achieved double-digit growth in its most recent quarter, fueled by international sales and the recent U.S. launch of Whitening Quick Dissolving Strips, the firm said Oct. 16
You may also be interested in...
Johnson & Johnson executives are touting the strength of the firm's consumer products businesses as they implement a plan to generate up to $1.6 billion in savings through consolidations and layoffs in J&J's pharmaceutical and medical device operations
Johnson & Johnson and Pfizer's divestiture of the Zantac, Cortizone, Unisom and Balmex brands satisfies the Federal Trade Commission's anticompetitive complaint about J&J's acquisition of Pfizer's consumer healthcare business
Under CEO Erik Fyrwald, IFF is committed to improving commercial execution across its four businesses after five years of overall underperformance.